Viewing Study NCT05013268


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2025-12-28 @ 4:58 AM
Study NCT ID: NCT05013268
Status: UNKNOWN
Last Update Posted: 2021-08-24
First Post: 2021-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module